50 related articles for article (PubMed ID: 33258543)
1. Long-term effects of weight-reducing drugs in people with hypertension.
Siebenhofer A; Winterholer S; Jeitler K; Horvath K; Berghold A; Krenn C; Semlitsch T
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD007654. PubMed ID: 33454957
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand?
Tak YJ; Lee SY
Curr Obes Rep; 2021 Mar; 10(1):14-30. PubMed ID: 33410104
[TBL] [Abstract][Full Text] [Related]
3. Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022.
Bays HE; Fitch A; Christensen S; Burridge K; Tondt J
Obes Pillars; 2022 Jun; 2():100018. PubMed ID: 37990711
[TBL] [Abstract][Full Text] [Related]
4. Unraveling the serotonin saga: from discovery to weight regulation and beyond - a comprehensive scientific review.
Conde K; Fang S; Xu Y
Cell Biosci; 2023 Aug; 13(1):143. PubMed ID: 37550777
[TBL] [Abstract][Full Text] [Related]
5. Obesity, diabetes, and cancer: epidemiology, pathophysiology, and potential interventions.
de Andrade Mesquita L; Wayerbacher LF; Schwartsmann G; Gerchman F
Arch Endocrinol Metab; 2023 Jun; 67(6):e000647. PubMed ID: 37364149
[TBL] [Abstract][Full Text] [Related]
6. Use of weight loss medications in relation with prostate, colorectal and male breast cancers among older men: SEER-Medicare 2007-2015.
Lopez DS; Kim H; Polychronopoulou E; Torres-Sanchez LE; Villasante-Tezanos A; Baillargeon J; Canfield S; Kuo YF
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8255-8265. PubMed ID: 37067547
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy of obesity: an update on the available medications and drugs under investigation.
Chakhtoura M; Haber R; Ghezzawi M; Rhayem C; Tcheroyan R; Mantzoros CS
EClinicalMedicine; 2023 Apr; 58():101882. PubMed ID: 36992862
[TBL] [Abstract][Full Text] [Related]
8. 5-HT
Przegaliński E; Witek K; Wydra K; Kotlińska JH; Filip M
Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986191
[TBL] [Abstract][Full Text] [Related]
9. Defining Predictors of Weight Loss Response to Lorcaserin.
Sideri Gugger A; Dimino C; Panigrahi SK; Mayer L; Smiley RM; Korner J; Wardlaw SL
J Clin Endocrinol Metab; 2023 Aug; 108(9):2262-2271. PubMed ID: 36897161
[TBL] [Abstract][Full Text] [Related]
10. Neural circuits controlling choice behavior in opioid addiction.
Chang VN; Peters J
Neuropharmacology; 2023 Mar; 226():109407. PubMed ID: 36592884
[TBL] [Abstract][Full Text] [Related]
11. Varenicline and Lorcaserin for Smoking Cessation and Weight Gain Prevention: A Randomized Clinical Trial.
Hurt RT; Croghan IT; Schroeder DR; Choi DS; Fischer K; Fokken S; Ebbert JO
Mayo Clin Proc Innov Qual Outcomes; 2022 Oct; 6(5):465-474. PubMed ID: 36160639
[TBL] [Abstract][Full Text] [Related]
12. Pilot study of extended-release lorcaserin for cocaine use disorder among men who have sex with men: A double-blind, placebo-controlled randomized trial.
Santos GM; Ikeda J; Coffin P; Walker JE; Matheson T; McLaughlin M; Jain J; Vittinghoff E; Batki SL
PLoS One; 2021; 16(7):e0254724. PubMed ID: 34265007
[TBL] [Abstract][Full Text] [Related]
13. The Triple Health Threat of Diabetes, Obesity, and Cancer-Epidemiology, Disparities, Mechanisms, and Interventions.
Brown JC; Carson TL; Thompson HJ; Agurs-Collins T
Obesity (Silver Spring); 2021 Jun; 29(6):954-959. PubMed ID: 34029445
[TBL] [Abstract][Full Text] [Related]
14. Is lorcaserin really associated with increased risk of cancer? A systematic review and meta-analysis.
de Andrade Mesquita L; Fagundes Piccoli G; Richter da Natividade G; Frison Spiazzi B; Colpani V; Gerchman F
Obes Rev; 2021 Mar; 22(3):e13170. PubMed ID: 33258543
[TBL] [Abstract][Full Text] [Related]
15. Cancer Risk Associated with Lorcaserin - The FDA's Review of the CAMELLIA-TIMI 61 Trial.
Sharretts J; Galescu O; Gomatam S; Andraca-Carrera E; Hampp C; Yanoff L
N Engl J Med; 2020 Sep; 383(11):1000-1002. PubMed ID: 32905671
[No Abstract] [Full Text] [Related]
16. Efficacy and safety of lorcaserin in obesity: a systematic review and meta-analysis of randomized controlled trials.
Singh AK; Singh R
Expert Rev Clin Pharmacol; 2020 Feb; 13(2):183-190. PubMed ID: 31815555
[No Abstract] [Full Text] [Related]
17. Efficacy and safety of lorcaserin in obese adults: a meta-analysis of 1-year randomized controlled trials (RCTs) and narrative review on short-term RCTs.
Chan EW; He Y; Chui CS; Wong AY; Lau WC; Wong IC
Obes Rev; 2013 May; 14(5):383-92. PubMed ID: 23331711
[TBL] [Abstract][Full Text] [Related]
18. Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis.
Khera R; Murad MH; Chandar AK; Dulai PS; Wang Z; Prokop LJ; Loomba R; Camilleri M; Singh S
JAMA; 2016 Jun; 315(22):2424-34. PubMed ID: 27299618
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
